COMP <GO>
ICLR vs JNJ // FORWARD P/E MULTIPLE
ICON plc (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ICLR 2
— JNJ 10
▲ FORWARD P/E MULTIPLE LEADER: JNJ
LAST: $211.36 (-1.91%) • MKT CAP: $16.50B
forward-pe
66.9x
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
forward-pe
23.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICLR VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICLR | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 25.50% | -22.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 18.5x | +13.20 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 5.22% | 2.97% | +2.25 | ICLR | /fcf-yield <GO> |
| Operating Margin | 5.40% | 34.70% | -29.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 28.50% | -25.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 0.80% | 6.00% | -5.20 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.20 | 5.59 | -3.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.20% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.1 | 60.4 | +13.72 | ICLR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.08 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 66.9x | 23.0x | +43.90 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.50B | $662.49B | -$645.99B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICLR REV | JNJ REV | ICLR GROSS % | JNJ GROSS % | ICLR FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.25B | $94.19B | 44.0% | 67.9% | $862.0M | $19.70B |
| FY 2024 | $8.19B | $88.82B | 28.6% | 69.1% | $1.12B | $19.84B |
| FY 2023 | $8.05B | $85.16B | 44.0% | 44.0% | $798.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICLR // BETA 1.08
JNJ // BETA 1.08